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better will earn three CME credits.1. The clinical symptoms of interstitial cystitis include:
A. Frequency
B. Bladder pain
C. Urgency
D. Nocturia
E. All of the above
Urol Sci 2015;26(4):225e229
2. Which of the following serum biomarkers was not found to
increase in patients with interstitial cystitis?
A. IL-6
B. TNF-a
C. IL-8
D. PSA
E. Nerve growth factor
Urol Sci 2015;26(4):225e229http://dx.doi.org/10.1016/S1879-5226(15)00595-3
1879-52263. In patients with interstitial cystitis, mast cells are associated
with:
A. Bladder inﬂammation
B. Bladder pain
C. Small bladder capacity
D. Ulcer type IC
E. All of the above
Urol Sci 2015;26(4):225e229
4. Which of the following statements is not correct?
A. Upper tract urothelial carcinomas are tumors derived from
the urothelium along the upper urinary tract.
B. Upper tract urothelial carcinomas account for only 5% of
urinary tract carcinomas worldwide.
C. Upper tract urothelial carcinomas have been described as
having a low incidence in Taiwanese populations.
D. Radical nephroureterectomy with bladder cuff excision is the
gold standard treatment for upper tract urothelial carcinomas.
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A. After optimal surgical treatment of upper tract urothelial
carcinomas (UTUC), the 5-year cancer-speciﬁc mortality
rates are very low.
B. The prognostic risk factors of UTUC recurrence and survival
are fully understood.
C. Considering the location of UTUC in the upper urinary tract,
radical nephroureterectomy with bladder cuff excision may
not be needed in every patient.
D. It has been reported that Taiwanese populations have high
incidence of UTUC at designated geographic locations with
speciﬁc exposure histories.
Urol Sci 2015;26(4):230e2346. Which of the following markers have been investigated as po-
tential prognostic factors in patients with upper tract urothelial
carcinomas?
A. P53
B. Cyclooxygenase-2
C. TG-interacting factor
D. Nuclear factor-kB
E. All of the above
Urol Sci 2015;26(4):230e234
Volume 26 Issue 3
Answers:
1. (B) 2. (D) 3. (A) 4. (D) 5. (D) 6. (D) 7. (C) 8. (B) 9. (D)
